We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$46.8B
AUM Growth
-$2.48B
(-5%)
Cap. Flow
-$831M
Cap. Flow
% of AUM
-1.77%
Top 10 Holdings %
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Crown Castle
CCI
|
+$130M |
| 2 |
Amgen
AMGN
|
+$96.1M |
| 3 |
Progressive
PGR
|
+$94.9M |
| 4 |
AbbVie
ABBV
|
+$77.1M |
| 5 |
Kenvue
KVUE
|
+$75.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$148M |
| 2 |
Johnson & Johnson
JNJ
|
+$147M |
| 3 |
LyondellBasell Industries
LYB
|
+$108M |
| 4 |
Dollar General
DG
|
+$91.2M |
| 5 |
ExxonMobil
XOM
|
+$87.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.48% |
| 2 | Healthcare | 17.42% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 9.71% |
| 5 | Communication Services | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPL
276
PPL Corp
PPL
$27.3B
| $19.3M | 0.04% |
818,070
-70,301
| -8% | -$1.82M |
|
277
FMC
FMC
$1.39B
| $18.8M | 0.04% |
281,064
-237,927
| -46% | -$20.6M |
|
278
Nucor
NUE
$59.7B
| $18.8M | 0.04% |
120,201
-4,148
| -3% | -$687K |
|
279
Textron
TXT
$15.8B
| $18.6M | 0.04% |
238,290
-39,698
| -14% | -$2.96M |
|
280
STAAR Surgical
STAA
$1.14B
| $18.4M | 0.04% |
458,430
-171
| -0% | -$8.01K |
|
281
PayPal
PYPL
$51.5B
| $18.4M | 0.04% |
314,337
+28,956
| +10% | +$1.89M |
|
282
Conagra Brands
CAG
$7.43B
| $18.3M | 0.04% |
666,775
+17,412
| +3% | +$537K |
|
|
283
Dollar General
DG
$27.8B
| $18M | 0.04% |
170,418
-612,020
| -78% | -$91.2M |
|
284
Phathom Pharmaceuticals
PHAT
$931M
| $18M | 0.04% |
1,732,172
-24,955
| -1% | -$342K |
|
285
W.W. Grainger
GWW
$65.6B
| $17.7M | 0.04% |
25,542
+2,503
| +11% | +$1.81M |
|
286
Paycom
PAYC
$7.57B
| $17.6M | 0.04% |
67,741
+35,423
| +110% | +$10.8M |
|
|
PXD
287
DELISTED
Pioneer Natural Resource Co.
PXD
| $17.3M | 0.04% |
75,581
-32,761
| -30% | -$7.46M |
|
288
MongoDB
MDB
$25B
| $17.2M | 0.04% |
49,789
-73,503
| -60% | -$27.9M |
|
289
CF Industries
CF
$18.9B
| $17.2M | 0.04% |
200,556
+3,497
| +2% | +$276K |
|
290
D.R. Horton
DHI
$42B
| $17.2M | 0.04% |
159,990
-8,233
| -5% | -$986K |
|
291
Bunge Global
BG
$22.7B
| $17.1M | 0.04% |
157,904
-51,015
| -24% | -$5.59M |
|
292
Fidelity National Information Services
FIS
$23.2B
| $16.9M | 0.04% |
306,229
-117,980
| -28% | -$6.79M |
|
293
Lithia Motors
LAD
$8.12B
| $16.8M | 0.04% |
57,050
-10,940
| -16% | -$3.33M |
|
294
Builders FirstSource
BLDR
$7.86B
| $16.8M | 0.04% |
135,293
-12,162
| -8% | -$1.68M |
|
295
Eaton
ETN
$149B
| $16.8M | 0.04% |
78,576
-3,413
| -4% | -$736K |
|
296
BridgeBio Pharma
BBIO
$16.4B
| $16.7M | 0.04% |
632,710
-447,549
| -41% | -$12.7M |
|
297
Cintas
CTAS
$86B
| $16.5M | 0.04% |
137,124
-6,808
| -5% | -$848K |
|
298
Cencora
COR
$62.2B
| $16.4M | 0.04% |
91,258
+7,221
| +9% | +$1.33M |
|
299
Edwards Lifesciences
EW
$48.2B
| $16.1M | 0.03% |
232,293
-9,171
| -4% | -$737K |
|
300
CSX Corp
CSX
$94.9B
| $16M | 0.03% |
520,088
-92,272
| -15% | -$2.92M |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
- Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
- Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
- Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
- Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
- Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.
Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.